Natural History Studies: Launch With Care And Consider Alternative Evidence For Drug Approval, FDA’s Marks Says

Rocket launch
Launching natural history studies requires careful consideration, CBER Director Peter Marks said. • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards